English
This article is from World Journal of Nuclear Medicine , volume 12 . Abstract Treatment of Graves' disease with iodine-131 (131I) is well-known; however, all patients do not respond to a single dose of 131I and may require higher and repeated doses. This study was carried out to identify the factors, which can predict treatment failure to a single dose of 131I treatment in these patients. Data of 150 patients with Graves' disease treated with 259-370 MBq of 131I followed-up for at least 1-year were retrospectively analyzed. Logistic regression analysis was used to predict factors which can predict treatment failure, such as age, sex, duration of disease, grade of goiter, duration of treatment with anti-thyroid drugs, mean dosage of anti-thyroid drugs used, 99mTc-pertechnetate (99mTcO4-) uptake at 20 min, dose of 131I administered, total triiodothyronine and thyroxine levels. Of the 150 patients, 25 patients required retreatment within 1 year of initial treatment with 131I. Logistic regression analysis revealed that male sex and 99mTcO4- uptake were associated with treatment failure. On receiver operating characteristic (ROC) curve analysis, area under the curve (AUC) was significan
Sign in with your free account to read, download EPUBs or listen.
Ebook · Factors Predicting Treatment Failure in Patients Treated with Iodine-131 for Graves' Disease. · Manohar, Kuruva, Mittal, Bhagwant Rai, Bhoil, Amit, Bhattacharya, Anish, Dutta, Pinaki, Bhansali, Anil · Internet Archive